查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2134687

肺炎診斷試劑盒市場：全球市場預測，2026-2032年

Pneumonia Diagnostics Kit Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，肺炎診斷試劑盒市場將成長至 30.1 億美元，複合年成長率為 11.15%。

主要市場統計數據
基準年 2025 14.3億美元
預計年份：2026年 15.7億美元
預測年份 2032 30.1億美元
複合年成長率 (%) 11.15%

肺炎診斷試劑盒：執行摘要

肺炎診斷試劑盒透過檢體體採集、病原體檢測以及在某些情況下進行的抗菌藥物敏感性試驗，幫助識別呼吸道感染疾病。其臨床價值在於能夠快速可靠地區分細菌、病毒、真菌和非感染性因素，尤其是在症狀重疊且需要快速制定治療方案時。其應用可行性取決於分析性能、工作流程的簡易性、生物安全要求、法規核准、保險報銷以及與臨床路徑的整合。

診斷方法正朝著更快、更分散的檢測方向發展。

診斷方法正從依賴集中式檢查室工作流程轉向檢查室檢測、床邊檢測和即時檢測相結合的模式。多重檢測、基於抗原的檢測和針對特定症候群的呼吸道病原體檢測組合有助於快速鑑別病原體，而數位連接則實現了與臨床醫生和公共衛生系統共用檢測結果。同時，合理使用抗生素的目標也增加了對能夠區分哪些患者可從抗生素治療中獲益、哪些患者需要支持性或替代療法的檢測的需求。然而，挑戰依然存在，包括檢體品質、疾病早期或低病原體濃度下的檢測靈敏度、供應的連續性、操作人員的培訓以及實驗室基礎設施的差異。

透過人工智慧 (AI) 加強分流、觀察解讀和監測

人工智慧正透過影像解讀、臨床決策支援、症狀和實驗室數據整合以及疫情監測等方式助力肺炎診斷。機器學習系統有助於確定X光相片的優先級，並識別需要複查的模式。演算法還能將影像學結果與年齡、生命徵象、實驗室觀察和微生物檢測結果結合，輔助風險分層。這些工具的最佳應用方式是作為輔助臨床醫師的系統，而非取代傳統的診斷方法。尤其需要注意的是，其效能可能因影像設備、醫療環境和疾病流行程度的不同而有所差異，因此在不同人群中檢驗、確保其可解釋性、保障網路安全、保證資料品質以及接受監管仍然至關重要。

區域洞察：基礎設施和准入決定診斷重點。

在北美，重點在於快速分子診斷流程、合理使用抗生素、提升醫院容量以及與電子健康記錄的整合。在歐洲，重點在於標準化評估、跨境監測以及基於健全檢查室網路的合理使用抗生素。亞太地區兼具先進的都市區檢查室、高患者量醫院和資源匱乏的農村醫療機構，因此對攜帶式、可靠且易於使用的檢測套組有著迫切的需求。拉丁美洲的特徵是醫療資源取得不均、呼吸道疾病監測需求以及分散式檢查的重要性。在中東，優先事項是現代化的醫院診斷和災害應變準備，同時解決人才和採購能力的差距。非洲迫切需要價格合理、適合現場使用的檢測方法、可靠的供應鏈以及即使在檢測能力和通訊基礎設施有限的情況下也能發揮作用的診斷方法。

群體特定見解：政策協調和共用基礎設施的重要性

東南亞國協雖然醫療衛生系統能力存在差異，但受益於可互通的監測系統、價格合理且分散的分散式檢查以及協調一致的採購機制。金磚國家成員國既面臨先進的研究環境，也面臨醫療資源取得的巨大差距，因此可擴展的平台、在地化的生產能力和靈活的監管流程至關重要。歐盟受益於統一的標準和跨境衛生合作，並繼續優先考慮證據品質和負責任的抗菌藥物使用。七國集團（G7）體系普遍強調高績效檢測、融入臨床實務以及關鍵供應鏈的韌性。海灣合作理事會（GCC）國家正在投資建設先進的醫療衛生基礎設施和集中式品管體系，同時推動人力資源發展和互通性的工作。北約成員國尤其重視韌性診斷、緊急應變、部署能力以及危機期間的醫療衛生連續性。

國別洞察：國家能力決定實施路徑

澳洲和加拿大優先考慮地域分散的醫療保健、檢查室間協作以及主要城市以外地區的可靠檢測。巴西、墨西哥、印度和南非需要能夠在公私混合醫療體系中運作的解決方案，並將可負擔性、分散化和人力資源發展視為關鍵考量。中國、日本和韓國兼具強大的技術能力、大規模的醫院需求、監管要求以及對自動化和整合診斷的重視。法國、德國、義大利、西班牙和英國則著重於臨床證據、管理、醫院效率以及與國家和地區醫療保健體係要求的契合度。俄羅斯的診斷格局受國內產能、供應連續性和最新檢測技術的取得途徑的影響。在美國，快速臨床決策、保險報銷、檢查室法規以及與不同醫療保健機構的整合等因素共同塑造了醫療需求。

給領導者的建議：建立證據、韌性與臨床適用性

產業領導者應優先考慮具有臨床意義的性能證據，涵蓋各個年齡層、病原體類型、檢體條件和醫療環境，而非僅依賴分析結果。產品設計應支援簡化的工作流程、清晰的解讀、品管以及在基礎設施允許的情況下實現互聯互通，同時在資源受限的環境中保持離線功能。與醫院、檢查室、公共衛生機構和當地醫療服務提供者夥伴關係將有助於改善檢驗和部署。領導者還應規劃臨床路徑，重點關注供應鏈韌性、透明的人工智慧管治、網路安全、監管差異以及管理責任。培訓、服務支援和上市後監測應被視為產品交付的核心組成部分，而非可選項。

調查方法：基於證據的市場分析

本執行摘要分析了「肺炎診斷試劑盒」這個市場類別，整合了既有的診斷、醫療服務、監管和技術的考量。評估透過對診療路徑、檢查室基礎設施、分散化需求、管理重點、數位化醫療準備和應用障礙的定性分析，比較了不同地區、國家和跨國企業集團的現狀。本摘要有意省略了市場規模估算和預測、市場佔有率、預測以及公司特定聲明。為便於實際決策，建議參考最新的監管文件、臨床指南、同行評審的檢驗研究、採購標準和國家級醫療衛生系統數據，以補充本摘要的結論。

結論：可靠且易於獲得的檢測對於改善肺炎治療至關重要。

肺炎診斷試劑盒的價值在於其能夠快速提供可靠結果、融入實際臨床工作流程，並適用於資源充足和資源匱乏的環境。儘管多參數檢測、分散化​​、數位化連接和人工智慧正在重塑這一領域，但其應用仍取決於實證醫學證據、價格可負擔性、品質保證以及與醫療保健系統的整合。那些能夠將產品性能與妥善管理、充分準備、公平獲取和有效部署相結合的領導者，將更有利於支持及時治療和加強呼吸系統疾病監測。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 肺炎診斷試劑盒市場：依產品類型分類

  • 分子診斷試劑盒
    • PCR試劑盒
      • 即時PCR試劑盒
      • 多重PCR試劑盒
    • 等溫擴增試劑盒
    • 定序盒
  • 免疫檢測盒
    • 快速側向流動檢測套組
    • ELISA試劑盒
  • 微生物試劑盒
    • 培養試劑盒
    • 抗菌藥物敏感性測試試劑盒

第8章：肺炎診斷試劑盒市場：依樣本類型分類

  • 呼吸道檢體
    • 痰
    • 鼻咽拭子
    • 口腔和咽拭子
    • 支氣管肺泡灌洗液
    • 氣管內吸出物
  • 血液檢體
    • 全血
    • 血清
    • 電漿
  • 尿液檢體
  • 胸腔積水

第9章：肺炎診斷試劑盒市場：依技術分類

  • 免疫檢測
    • CLIA
    • ELISA
    • LFA
  • LAMP
  • 次世代定序
    • Illumina
    • Ion Torrent
    • PacBio
  • PCR
    • 數位PCR
    • 即時PCR

第10章 肺炎診斷試劑盒市場：依年齡層別分類

  • 新生
  • 兒童
    • 嬰兒
    • 孩子們
  • 成人
  • 老年人

第11章 肺炎診斷試劑盒市場：依通路分類

  • 直銷
  • 銷售代理
  • 線上平台

第12章 肺炎診斷試劑盒市場：依最終用戶分類

  • 醫院
    • 三級醫療醫院
    • 二級醫療機構
  • 診斷檢查室
    • 獨立檢測實驗室
    • 醫院實驗室
  • 診所和私人診所
  • 照護端環境
    • 急診中心
    • 急診室
  • 居家醫療
  • 學術研究機構

第13章 肺炎診斷試劑盒市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 肺炎診斷試劑盒市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 肺炎診斷試劑盒市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • Acumen Diagnostics Pte Ltd.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Cardinal Health Inc.
  • Cepheid
  • Diamedica SIA
  • DiaSorin SpA
  • Hologic, Inc.
  • Laboratory Corporation of America Holdings
  • LGC Science Group Holdings Ltd.
  • Meridian Bioscience, Inc.
  • OpGen, Inc.
  • Ortho-Clinical Diagnostics
  • PerkinElmer, Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Quidel Corporation
  • Roche Diagnostics International AG
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc

第18章 主要專家

Product Code: MRR-F774F633703D

The Pneumonia Diagnostics Kit Market is projected to grow by USD 3.01 billion at a CAGR of 11.15% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.43 billion
Estimated Year [2026] USD 1.57 billion
Forecast Year [2032] USD 3.01 billion
CAGR (%) 11.15%

Pneumonia Diagnostics Kits: Executive Summary

Pneumonia diagnostics kits support the identification of respiratory infection through specimen collection, pathogen detection, and, in some settings, antimicrobial susceptibility assessment. Their clinical value is shaped by the need for rapid, reliable differentiation between bacterial, viral, fungal, and noninfectious causes, particularly where symptoms overlap and treatment decisions must be made quickly. Adoption depends on analytical performance, workflow simplicity, biosafety requirements, regulatory authorization, reimbursement, and integration with clinical pathways.

Diagnostic Practice Is Shifting Toward Faster, Decentralized Testing

The diagnostic landscape is moving from reliance on centralized laboratory workflows toward a combination of laboratory, near-patient, and point-of-care testing. Multiplex molecular methods, antigen-based assays, and syndromic respiratory panels are supporting faster differentiation of pathogens, while digital connectivity enables results to be shared with clinicians and public-health systems. At the same time, stewardship goals are increasing demand for tests that can help distinguish patients who may benefit from antibiotics from those requiring supportive care or alternative treatment. Persistent constraints include specimen quality, test sensitivity in early or low-pathogen disease, supply continuity, operator training, and uneven laboratory infrastructure.

Artificial Intelligence Strengthens Triage, Interpretation, and Surveillance

Artificial intelligence is contributing to pneumonia diagnosis through image interpretation, clinical decision support, symptom and laboratory-data integration, and outbreak surveillance. Machine-learning systems can help prioritize radiographs or flag patterns for review, while algorithms may combine imaging with age, vital signs, laboratory findings, and microbiology results to support risk stratification. These tools are most useful when deployed as clinician-support systems rather than autonomous replacements for diagnosis. Validation across diverse populations, explainability, cybersecurity, data quality, and regulatory oversight remain essential, especially because performance can vary across imaging equipment, care settings, and disease prevalence.

Regional Insights: Infrastructure and Access Define Diagnostic Priorities

North America emphasizes rapid molecular workflows, antimicrobial stewardship, hospital throughput, and integration with electronic health records. Europe combines strong laboratory networks with emphasis on standardized evaluation, cross-border surveillance, and appropriate antibiotic use. Asia-Pacific presents a broad mix of advanced urban laboratories, high-volume hospitals, and resource-constrained rural settings, creating demand for portable, robust, and easy-to-operate kits. Latin America is shaped by uneven access, respiratory disease surveillance needs, and the importance of decentralized testing. The Middle East is prioritizing modern hospital diagnostics and preparedness while addressing workforce and procurement variation. Africa faces substantial needs for affordable, field-suitable testing, reliable supply chains, and diagnostic approaches that function where laboratory capacity and connectivity are limited.

Group Insights: Policy Alignment and Shared Infrastructure Matter

ASEAN countries face varied health-system capacity and benefit from interoperable surveillance, affordable decentralized testing, and coordinated procurement. BRICS members span advanced research environments and major access gaps, making scalable platforms, local manufacturing capability, and adaptable regulatory pathways important. The European Union benefits from harmonized standards and cross-border health cooperation, while continuing to focus on evidence quality and responsible antimicrobial use. G7 systems generally emphasize high-performance testing, clinical integration, and resilience of critical supply chains. GCC countries are investing in advanced healthcare infrastructure and centralized quality systems while addressing workforce development and interoperability. NATO members have additional interest in resilient diagnostics, emergency preparedness, deployability, and continuity of care during crises.

Country Insights: National Capacity Shapes Adoption Pathways

Australia and Canada emphasize geographically distributed care, laboratory connectivity, and dependable testing outside major cities. Brazil, Mexico, India, and South Africa require solutions that can operate across mixed public and private systems, with affordability, decentralization, and workforce training as central considerations. China, Japan, and South Korea combine strong technology capabilities with large-scale hospital demand, regulatory requirements, and interest in automation and integrated diagnostics. France, Germany, Italy, Spain, and the United Kingdom focus on clinical evidence, stewardship, hospital efficiency, and alignment with national or regional health-system requirements. Russia's diagnostic environment is influenced by domestic capacity, supply continuity, and access to modern laboratory technologies. Across the United States, demand is shaped by rapid clinical decision-making, reimbursement considerations, laboratory regulation, and integration into diverse care settings.

Recommendations for Leaders: Build Evidence, Resilience, and Clinical Fit

Industry leaders should prioritize clinically meaningful performance evidence across age groups, pathogen types, specimen conditions, and care settings rather than relying only on analytical claims. Product design should support simple workflows, clear interpretation, quality control, and connectivity where infrastructure allows, while retaining offline functionality for lower-resource environments. Partnerships with hospitals, laboratories, public-health agencies, and community providers can improve validation and implementation. Leaders should also plan for supply-chain resilience, transparent AI governance, cybersecurity, regulatory variation, and stewardship-oriented clinical pathways. Training, service support, and post-market surveillance should be treated as core components of the offering, not optional additions.

Research Methodology: Evidence-Based Market Interpretation

This executive summary uses the supplied market category-pneumonia diagnostics kits-as the analytical scope and synthesizes established diagnostic, healthcare-delivery, regulatory, and technology considerations. The assessment compares regional, country, and multinational-group conditions through qualitative review of care pathways, laboratory infrastructure, decentralization needs, stewardship priorities, digital-health readiness, and implementation barriers. It deliberately excludes market estimates, market sizing, market shares, forecasts, and company-specific claims. Conclusions should be supplemented with current regulatory documents, clinical guidelines, peer-reviewed validation studies, procurement standards, and country-level health-system data before operational decisions are made.

Conclusion: Reliable, Accessible Testing Is Central to Better Pneumonia Care

Pneumonia diagnostics kits are most valuable when they deliver dependable results quickly, fit real clinical workflows, and remain usable across both advanced and resource-constrained settings. The sector is being reshaped by multiplex testing, decentralization, digital connectivity, and artificial intelligence, but adoption will depend on evidence, affordability, quality assurance, and health-system integration. Leaders that align product performance with stewardship, preparedness, equitable access, and resilient implementation will be better positioned to support timely treatment and stronger respiratory-disease surveillance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Pneumonia Diagnostics Kit Market, by Product Type

  • 7.1. Introduction
  • 7.2. Molecular Diagnostics Kits
    • 7.2.1. PCR Kits
      • 7.2.1.1. Real-Time PCR Kits
      • 7.2.1.2. Multiplex PCR Kits
    • 7.2.2. Isothermal Amplification Kits
    • 7.2.3. Sequencing Kits
  • 7.3. Immunoassay Kits
    • 7.3.1. Rapid Lateral Flow Kits
    • 7.3.2. ELISA Kits
  • 7.4. Microbiology Kits
    • 7.4.1. Culture Kits
    • 7.4.2. Susceptibility Testing Kits

8. Pneumonia Diagnostics Kit Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Respiratory Samples
    • 8.2.1. Sputum
    • 8.2.2. Nasopharyngeal Swab
    • 8.2.3. Oropharyngeal Swab
    • 8.2.4. Bronchoalveolar Lavage
    • 8.2.5. Endotracheal Aspirate
  • 8.3. Blood Samples
    • 8.3.1. Whole Blood
    • 8.3.2. Serum
    • 8.3.3. Plasma
  • 8.4. Urine Samples
  • 8.5. Pleural Fluid

9. Pneumonia Diagnostics Kit Market, by Technology

  • 9.1. Introduction
  • 9.2. Immunoassay
    • 9.2.1. CLIA
    • 9.2.2. ELISA
    • 9.2.3. LFA
  • 9.3. LAMP
  • 9.4. Next-Gen Sequencing
    • 9.4.1. Illumina
    • 9.4.2. Ion Torrent
    • 9.4.3. PacBio
  • 9.5. PCR
    • 9.5.1. Digital PCR
    • 9.5.2. Real-Time PCR

10. Pneumonia Diagnostics Kit Market, by Age Group

  • 10.1. Introduction
  • 10.2. Neonates
  • 10.3. Pediatric
    • 10.3.1. Infants
    • 10.3.2. Children
  • 10.4. Adults
  • 10.5. Geriatric

11. Pneumonia Diagnostics Kit Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Direct Sales
  • 11.3. Distributors
  • 11.4. Online Platforms

12. Pneumonia Diagnostics Kit Market, by End User

  • 12.1. Introduction
  • 12.2. Hospitals
    • 12.2.1. Tertiary Care Hospitals
    • 12.2.2. Secondary Care Hospitals
  • 12.3. Diagnostic Laboratories
    • 12.3.1. Independent Laboratories
    • 12.3.2. Hospital Laboratories
  • 12.4. Clinics And Physician Offices
  • 12.5. Point Of Care Settings
    • 12.5.1. Urgent Care Centers
    • 12.5.2. Emergency Departments
  • 12.6. Home Care Settings
  • 12.7. Academic And Research Institutes

13. Pneumonia Diagnostics Kit Market, by Region

  • 13.1. Introduction
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Europe
  • 13.6. Middle East
  • 13.7. Africa

14. Pneumonia Diagnostics Kit Market, by Group

  • 14.1. Introduction
  • 14.2. ASEAN
  • 14.3. GCC
  • 14.4. European Union
  • 14.5. BRICS
  • 14.6. G7
  • 14.7. NATO

15. Pneumonia Diagnostics Kit Market, by Country

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. United Kingdom
  • 15.7. Germany
  • 15.8. France
  • 15.9. Russia
  • 15.10. Italy
  • 15.11. Spain
  • 15.12. China
  • 15.13. India
  • 15.14. Japan
  • 15.15. Australia
  • 15.16. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. Market Concentration Analysis, 2025
    • 16.2.1. Concentration Ratio (CR)
    • 16.2.2. Herfindahl Hirschman Index (HHI)
  • 16.3. Recent Developments & Impact Analysis, 2025
  • 16.4. Product Portfolio Analysis, 2025
  • 16.5. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. Acumen Diagnostics Pte Ltd.
  • 17.3. Beckman Coulter, Inc.
  • 17.4. Becton, Dickinson and Company
  • 17.5. Bio-Rad Laboratories, Inc.
  • 17.6. bioMerieux SA
  • 17.7. Cardinal Health Inc.
  • 17.8. Cepheid
  • 17.9. Diamedica SIA
  • 17.10. DiaSorin S.p.A.
  • 17.11. Hologic, Inc.
  • 17.12. Laboratory Corporation of America Holdings
  • 17.13. LGC Science Group Holdings Ltd.
  • 17.14. Meridian Bioscience, Inc.
  • 17.15. OpGen, Inc.
  • 17.16. Ortho-Clinical Diagnostics
  • 17.17. PerkinElmer, Inc.
  • 17.18. QIAGEN N.V.
  • 17.19. Quest Diagnostics Inc.
  • 17.20. Quidel Corporation
  • 17.21. Roche Diagnostics International AG
  • 17.22. Siemens Healthineers AG
  • 17.23. Sysmex Corporation
  • 17.24. Thermo Fisher Scientific Inc.
  • 17.25. Trinity Biotech Plc

18. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Pneumonia Diagnostics Kit Market, Years Considered for the Study
  • FIGURE 2. Global Pneumonia Diagnostics Kit Market, Research Design
  • FIGURE 3. Global Pneumonia Diagnostics Kit Market, Research Framework
  • FIGURE 4. Global Pneumonia Diagnostics Kit Market, Data Triangulation
  • FIGURE 5. Global Pneumonia Diagnostics Kit Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Pneumonia Diagnostics Kit Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Pneumonia Diagnostics Kit Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Pneumonia Diagnostics Kit Market Size, by Sample Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Pneumonia Diagnostics Kit Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Pneumonia Diagnostics Kit Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 11. Global Pneumonia Diagnostics Kit Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Pneumonia Diagnostics Kit Market Size, by Age Group, 2025 vs 2032 (%)
  • FIGURE 13. Global Pneumonia Diagnostics Kit Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Pneumonia Diagnostics Kit Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 15. Global Pneumonia Diagnostics Kit Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Pneumonia Diagnostics Kit Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 17. Global Pneumonia Diagnostics Kit Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Pneumonia Diagnostics Kit Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 19. Global Pneumonia Diagnostics Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Pneumonia Diagnostics Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Pneumonia Diagnostics Kit Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 22. Global Pneumonia Diagnostics Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global Pneumonia Diagnostics Kit Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Pneumonia Diagnostics Kit Market Segmentation & Coverage
  • TABLE 2. Global Pneumonia Diagnostics Kit Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Pneumonia Diagnostics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Molecular Diagnostics Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Molecular Diagnostics Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Molecular Diagnostics Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global PCR Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global PCR Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global PCR Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Real-Time PCR Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Real-Time PCR Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Real-Time PCR Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Multiplex PCR Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Multiplex PCR Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Multiplex PCR Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Isothermal Amplification Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Isothermal Amplification Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Isothermal Amplification Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Sequencing Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Sequencing Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Sequencing Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Immunoassay Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Immunoassay Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Immunoassay Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Rapid Lateral Flow Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Rapid Lateral Flow Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Rapid Lateral Flow Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global ELISA Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global ELISA Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global ELISA Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Microbiology Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Microbiology Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Microbiology Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Culture Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Culture Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Culture Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Susceptibility Testing Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Susceptibility Testing Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Susceptibility Testing Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Pneumonia Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 41. Global Respiratory Samples Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Respiratory Samples Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Respiratory Samples Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Sputum Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Sputum Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Sputum Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Nasopharyngeal Swab Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Nasopharyngeal Swab Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Nasopharyngeal Swab Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Oropharyngeal Swab Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Global Oropharyngeal Swab Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 52. Global Oropharyngeal Swab Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 53. Global Bronchoalveolar Lavage Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Global Bronchoalveolar Lavage Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 55. Global Bronchoalveolar Lavage Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 56. Global Endotracheal Aspirate Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Endotracheal Aspirate Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Endotracheal Aspirate Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Blood Samples Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Blood Samples Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Blood Samples Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 64. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 65. Global Serum Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Global Serum Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 67. Global Serum Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 68. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 70. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 71. Global Urine Samples Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Global Urine Samples Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 73. Global Urine Samples Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 74. Global Pleural Fluid Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 75. Global Pleural Fluid Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 76. Global Pleural Fluid Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 77. Global Pneumonia Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 78. Global Immunoassay Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. Global Immunoassay Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 80. Global Immunoassay Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 81. Global CLIA Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. Global CLIA Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 83. Global CLIA Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 84. Global ELISA Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 85. Global ELISA Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 86. Global ELISA Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 87. Global LFA Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 88. Global LFA Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 89. Global LFA Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 90. Global LAMP Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 91. Global LAMP Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 92. Global LAMP Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 93. Global Next-Gen Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 94. Global Next-Gen Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 95. Global Next-Gen Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 96. Global Illumina Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 97. Global Illumina Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 98. Global Illumina Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 99. Global Ion Torrent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 100. Global Ion Torrent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 101. Global Ion Torrent Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 102. Global PacBio Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 103. Global PacBio Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 104. Global PacBio Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 105. Global PCR Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 106. Global PCR Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 107. Global PCR Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 108. Global Digital PCR Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. Global Digital PCR Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 110. Global Digital PCR Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 111. Global Real-Time PCR Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 112. Global Real-Time PCR Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 113. Global Real-Time PCR Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 114. Global Pneumonia Diagnostics Kit Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 115. Global Neonates Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 116. Global Neonates Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 117. Global Neonates Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 118. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 119. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 120. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 121. Global Infants Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 122. Global Infants Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 123. Global Infants Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 124. Global Children Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 125. Global Children Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 126. Global Children Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 127. Global Adults Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 128. Global Adults Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 129. Global Adults Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 130. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 131. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 132. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 133. Global Pneumonia Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 134. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 135. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 136. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 137. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 138. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 139. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 140. Global Online Platforms Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 141. Global Online Platforms Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 142. Global Online Platforms Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 143. Global Pneumonia Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 144. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 145. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 146. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 147. Global Tertiary Care Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 148. Global Tertiary Care Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 149. Global Tertiary Care Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 150. Global Secondary Care Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 151. Global Secondary Care Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 152. Global Secondary Care Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 153. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 154. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 155. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 156. Global Independent Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 157. Global Independent Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 158. Global Independent Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 159. Global Hospital Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 160. Global Hospital Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 161. Global Hospital Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 162. Global Clinics And Physician Offices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 163. Global Clinics And Physician Offices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 164. Global Clinics And Physician Offices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 165. Global Point Of Care Settings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 166. Global Point Of Care Settings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 167. Global Point Of Care Settings Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 168. Global Urgent Care Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 169. Global Urgent Care Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 170. Global Urgent Care Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 171. Global Emergency Departments Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 172. Global Emergency Departments Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 173. Global Emergency Departments Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 174. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 175. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 176. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 177. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 178. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 179. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 180. Global Pneumonia Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 181. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 182. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 183. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Molecular Diagnostics Kits, 2017-2032 (USD Million)
  • TABLE 184. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by PCR Kits, 2017-2032 (USD Million)
  • TABLE 185. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Immunoassay Kits, 2017-2032 (USD Million)
  • TABLE 186. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Microbiology Kits, 2017-2032 (USD Million)
  • TABLE 187. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 188. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Respiratory Samples, 2017-2032 (USD Million)
  • TABLE 189. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Blood Samples, 2017-2032 (USD Million)
  • TABLE 190. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 191. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
  • TABLE 192. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Next-Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 193. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 194. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 195. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Pediatric, 2017-2032 (USD Million)
  • TABLE 196. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 197. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 198. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 199. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 200. Asia-Pacific Pneumonia Diagnostics Kit Market Size, by Point Of Care Settings, 2017-2032 (USD Million)
  • TABLE 201. North America Pneumonia Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 202. North America Pneumonia Diagnostics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 203. North America Pneumonia Diagnostics Kit Market Size, by Molecular Diagnostics Kits, 2017-2032 (USD Million)
  • TABLE 204. North America Pneumonia Diagnostics Kit Market Size, by PCR Kits, 2017-2032 (USD Million)
  • TABLE 205. North America Pneumonia Diagnostics Kit Market Size, by Immunoassay Kits, 2017-2032 (USD Million)
  • TABLE 206. North America Pneumonia Diagnostics Kit Market Size, by Microbiology Kits, 2017-2032 (USD Million)
  • TABLE 207. North America Pneumonia Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 208. North America Pneumonia Diagnostics Kit Market Size, by Respiratory Samples, 2017-2032 (USD Million)
  • TABLE 209. North America Pneumonia Diagnostics Kit Market Size, by Blood Samples, 2017-2032 (USD Million)
  • TABLE 210. North America Pneumonia Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 211. North America Pneumonia Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
  • TABLE 212. North America Pneumonia Diagnostics Kit Market Size, by Next-Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 213. North America Pneumonia Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 214. North America Pneumonia Diagnostics Kit Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 215. North America Pneumonia Diagnostics Kit Market Size, by Pediatric, 2017-2032 (USD Million)
  • TABLE 216. North America Pneumonia Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 217. North America Pneumonia Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 218. North America Pneumonia Diagnostics Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 219. North America Pneumonia Diagnostics Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 220. North America Pneumonia Diagnostics Kit Market Size, by Point Of Care Settings, 2017-2032 (USD Million)
  • TABLE 221. Latin America Pneumonia Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 222. Latin America Pneumonia Diagnostics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 223. Latin America Pneumonia Diagnostics Kit Market Size, by Molecular Diagnostics Kits, 2017-2032 (USD Million)
  • TABLE 224. Latin America Pneumonia Diagnostics Kit Market Size, by PCR Kits, 2017-2032 (USD Million)
  • TABLE 225. Latin America Pneumonia Diagnostics Kit Market Size, by Immunoassay Kits, 2017-2032 (USD Million)
  • TABLE 226. Latin America Pneumonia Diagnostics Kit Market Size, by Microbiology Kits, 2017-2032 (USD Million)
  • TABLE 227. Latin America Pneumonia Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 228. Latin America Pneumonia Diagnostics Kit Market Size, by Respiratory Samples, 2017-2032 (USD Million)
  • TABLE 229. Latin America Pneumonia Diagnostics Kit Market Size, by Blood Samples, 2017-2032 (USD Million)
  • TABLE 230. Latin America Pneumonia Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 231. Latin America Pneumonia Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
  • TABLE 232. Latin America Pneumonia Diagnostics Kit Market Size, by Next-Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 233. Latin America Pneumonia Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 234. Latin America Pneumonia Diagnostics Kit Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 235. Latin America Pneumonia Diagnostics Kit Market Size, by Pediatric, 2017-2032 (USD Million)
  • TABLE 236. Latin America Pneumonia Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 237. Latin America Pneumonia Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 238. Latin America Pneumonia Diagnostics Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 239. Latin America Pneumonia Diagnostics Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 240. Latin America Pneumonia Diagnostics Kit Market Size, by Point Of Care Settings, 2017-2032 (USD Million)
  • TABLE 241. Europe Pneumonia Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 242. Europe Pneumonia Diagnostics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 243. Europe Pneumonia Diagnostics Kit Market Size, by Molecular Diagnostics Kits, 2017-2032 (USD Million)
  • TABLE 244. Europe Pneumonia Diagnostics Kit Market Size, by PCR Kits, 2017-2032 (USD Million)
  • TABLE 245. Europe Pneumonia Diagnostics Kit Market Size, by Immunoassay Kits, 2017-2032 (USD Million)
  • TABLE 246. Europe Pneumonia Diagnostics Kit Market Size, by Microbiology Kits, 2017-2032 (USD Million)
  • TABLE 247. Europe Pneumonia Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 248. Europe Pneumonia Diagnostics Kit Market Size, by Respiratory Samples, 2017-2032 (USD Million)
  • TABLE 249. Europe Pneumonia Diagnostics Kit Market Size, by Blood Samples, 2017-2032 (USD Million)
  • TABLE 250. Europe Pneumonia Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 251. Europe Pneumonia Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
  • TABLE 252. Europe Pneumonia Diagnostics Kit Market Size, by Next-Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 253. Europe Pneumonia Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 254. Europe Pneumonia Diagnostics Kit Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 255. Europe Pneumonia Diagnostics Kit Market Size, by Pediatric, 2017-2032 (USD Million)
  • TABLE 256. Europe Pneumonia Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 257. Europe Pneumonia Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 258. Europe Pneumonia Diagnostics Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 259. Europe Pneumonia Diagnostics Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 260. Europe Pneumonia Diagnostics Kit Market Size, by Point Of Care Settings, 2017-2032 (USD Million)
  • TABLE 261. Middle East Pneumonia Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 262. Middle East Pneumonia Diagnostics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 263. Middle East Pneumonia Diagnostics Kit Market Size, by Molecular Diagnostics Kits, 2017-2032 (USD Million)
  • TABLE 264. Middle East Pneumonia Diagnostics Kit Market Size, by PCR Kits, 2017-2032 (USD Million)
  • TABLE 265. Middle East Pneumonia Diagnostics Kit Market Size, by Immunoassay Kits, 2017-2032 (USD Million)
  • TABLE 266. Middle East Pneumonia Diagnostics Kit Market Size, by Microbiology Kits, 2017-2032 (USD Million)
  • TABLE 267. Middle East Pneumonia Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 268. Middle East Pneumonia Diagnostics Kit Market Size, by Respiratory Samples, 2017-2032 (USD Million)
  • TABLE 269. Middle East Pneumonia Diagnostics Kit Market Size, by Blood Samples, 2017-2032 (USD Million)
  • TABLE 270. Middle East Pneumonia Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 271. Middle East Pneumonia Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
  • TABLE 272. Middle East Pneumonia Diagnostics Kit Market Size, by Next-Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 273. Middle East Pneumonia Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 274. Middle East Pneumonia Diagnostics Kit Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 275. Middle East Pneumonia Diagnostics Kit Market Size, by Pediatric, 2017-2032 (USD Million)
  • TABLE 276. Middle East Pneumonia Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 277. Middle East Pneumonia Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 278. Middle East Pneumonia Diagnostics Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 279. Middle East Pneumonia Diagnostics Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 280. Middle East Pneumonia Diagnostics Kit Market Size, by Point Of Care Settings, 2017-2032 (USD Million)
  • TABLE 281. Africa Pneumonia Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 282. Africa Pneumonia Diagnostics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 283. Africa Pneumonia Diagnostics Kit Market Size, by Molecular Diagnostics Kits, 2017-2032 (USD Million)
  • TABLE 284. Africa Pneumonia Diagnostics Kit Market Size, by PCR Kits, 2017-2032 (USD Million)
  • TABLE 285. Africa Pneumonia Diagnostics Kit Market Size, by Immunoassay Kits, 2017-2032 (USD Million)
  • TABLE 286. Africa Pneumonia Diagnostics Kit Market Size, by Microbiology Kits, 2017-2032 (USD Million)
  • TABLE 287. Africa Pneumonia Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 288. Africa Pneumonia Diagnostics Kit Market Size, by Respiratory Samples, 2017-2032 (USD Million)
  • TABLE 289. Africa Pneumonia Diagnostics Kit Market Size, by Blood Samples, 2017-2032 (USD Million)
  • TABLE 290. Africa Pneumonia Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 291. Africa Pneumonia Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
  • TABLE 292. Africa Pneumonia Diagnostics Kit Market Size, by Next-Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 293. Africa Pneumonia Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 294. Africa Pneumonia Diagnostics Kit Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 295. Africa Pneumonia Diagnostics Kit Market Size, by Pediatric, 2017-2032 (USD Million)
  • TABLE 296. Africa Pneumonia Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 297. Africa Pneumonia Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 298. Africa Pneumonia Diagnostics Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 299. Africa Pneumonia Diagnostics Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 300. Africa Pneumonia Diagnostics Kit Market Size, by Point Of Care Settings, 2017-2032 (USD Million)
  • TABLE 301. Global Pneumonia Diagnostics Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 302. ASEAN Pneumonia Diagnostics Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 303. ASEAN Pneumonia Diagnostics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 304. ASEAN Pneumonia Diagnostics Kit Market Size, by Molecular Diagnostics Kits, 2017-2032 (USD Million)
  • TABLE 305. ASEAN Pneumonia Diagnostics Kit Market Size, by PCR Kits, 2017-2032 (USD Million)
  • TABLE 306. ASEAN Pneumonia Diagnostics Kit Market Size, by Immunoassay Kits, 2017-2032 (USD Million)
  • TABLE 307. ASEAN Pneumonia Diagnostics Kit Market Size, by Microbiology Kits, 2017-2032 (USD Million)
  • TABLE 308. ASEAN Pneumonia Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 309. ASEAN Pneumonia Diagnostics Kit Market Size, by Respiratory Samples, 2017-2032 (USD Million)
  • TABLE 310. ASEAN Pneumonia Diagnostics Kit Market Size, by Blood Samples, 2017-2032 (USD Million)
  • TABLE 311. ASEAN Pneumonia Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 312. ASEAN Pneumonia Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
  • TABLE 313. ASEAN Pneumonia Diagnostics Kit Market Size, by Next-Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 314. ASEAN Pneumonia Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 315. ASEAN Pneumonia Diagnostics Kit Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 316. ASEAN Pneumonia Diagnostics Kit Market Size, by Pediatric, 2017-2032 (USD Million)
  • TABLE 317. ASEAN Pneumonia Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 318. ASEAN Pneumonia Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 319. ASEAN Pneumonia Diagnostics Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 320. ASEAN Pneumonia Diagnostics Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 321. ASEAN Pneumonia Diagnostics Kit Market Size, by Point Of Care Settings, 2017-2032 (USD Million)
  • TABLE 322. GCC Pneumonia Diagnostics Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 323. GCC Pneumonia Diagnostics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 324. GCC Pneumonia Diagnostics Kit Market Size, by Molecular Diagnostics Kits, 2017-2032 (USD Million)
  • TABLE 325. GCC Pneumonia Diagnostics Kit Market Size, by PCR Kits, 2017-2032 (USD Million)
  • TABLE 326. GCC Pneumonia Diagnostics Kit Market Size, by Immunoassay Kits, 2017-2032 (USD Million)
  • TABLE 327. GCC Pneumonia Diagnostics Kit Market Size, by Microbiology Kits, 2017-2032 (USD Million)
  • TABLE 328. GCC Pneumonia Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 329. GCC Pneumonia Diagnostics Kit Market Size, by Respiratory Samples, 2017-2032 (USD Million)
  • TABLE 330. GCC Pneumonia Diagnostics Kit Market Size, by Blood Samples, 2017-2032 (USD Million)
  • TABLE 331. GCC Pneumonia Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 332. GCC Pneumonia Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
  • TABLE 333. GCC Pneumonia Diagnostics Kit Market Size, by Next-Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 334. GCC Pneumonia Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 335. GCC Pneumonia Diagnostics Kit Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 336. GCC Pneumonia Diagnostics Kit Market Size, by Pediatric, 2017-2032 (USD Million)
  • TABLE 337. GCC Pneumonia Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 338. GCC Pneumonia Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 339. GCC Pneumonia Diagnostics Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 340. GCC Pneumonia Diagnostics Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 341. GCC Pneumonia Diagnostics Kit Market Size, by Point Of Care Settings, 2017-2032 (USD Million)
  • TABLE 342. European Union Pneumonia Diagnostics Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 343. European Union Pneumonia Diagnostics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 344. European Union Pneumonia Diagnostics Kit Market Size, by Molecular Diagnostics Kits, 2017-2032 (USD Million)
  • TABLE 345. European Union Pneumonia Diagnostics Kit Market Size, by PCR Kits, 2017-2032 (USD Million)
  • TABLE 346. European Union Pneumonia Diagnostics Kit Market Size, by Immunoassay Kits, 2017-2032 (USD Million)
  • TABLE 347. European Union Pneumonia Diagnostics Kit Market Size, by Microbiology Kits, 2017-2032 (USD Million)
  • TABLE 348. European Union Pneumonia Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 349. European Union Pneumonia Diagnostics Kit Market Size, by Respiratory Samples, 2017-2032 (USD Million)
  • TABLE 350. European Union Pneumonia Diagnostics Kit Market Size, by Blood Samples, 2017-2032 (USD Million)
  • TABLE 351. European Union Pneumonia Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 352. European Union Pneumonia Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
  • TABLE 353. European Union Pneumonia Diagnostics Kit Market Size, by Next-Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 354. European Union Pneumonia Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 355. European Union Pneumonia Diagnostics Kit Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 356. European Union Pneumonia Diagnostics Kit Market Size, by Pediatric, 2017-2032 (USD Million)
  • TABLE 357. European Union Pneumonia Diagno